Millennium Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Millennium Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-224,200	Closed	-$5.4M	–	7104
2023 Q1	$5.4M	Buy	+224,200	New	+$2.81M	﹤0.01%	2540

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Millennium Management's PRVB Position: Q2 2023 in Review

Millennium Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 1,085,705 shares — an estimated $26.2M sold.

Millennium Management first reported a position in PRVB in Q3 2019 and held it in 13 quarters. The position peaked at $26.2M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Millennium Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 1,085,705 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $26.2M.
Millennium Management first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 13 quarters.
Millennium Management's Provention Bio, Inc. Common Stock position peaked at $26.2M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.